Treatment of donor graft failure with nonmyeloablative conditioning of fludarabine, antithymocyte globulin and a second allogeneic hematopoietic transplantation.

Jabbour, E; Rondon, G; Anderlini, P; Giralt, S A; Couriel, D R; Champlin, R E; Khouri, I F

Jabbour, E; Rondon, G; Anderlini, P; Giralt, S A; Couriel, D R; Champlin, R E; Khouri, I F.

Affiliation

Jabbour E; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Bone Marrow Transplant ; 40(5): 431-5, 2007 Sep.

Article in En | MEDLINE | ID: mdl-17603511

Subject(s)

Antilymphocyte Serum/administration & dosage; Hematopoietic Stem Cell Transplantation/methods; Salvage Therapy/methods; Transplantation Conditioning/methods; Vidarabine/analogs & derivatives; Adult; Aged; Feasibility Studies; Female; Graft Rejection; Graft Survival; Graft vs Host Disease/drug therapy; Graft vs Host Disease/prevention & control; Hematopoiesis; Hematopoietic Stem Cell Transplantation/adverse effects; Humans; Male; Middle Aged; Pilot Projects; Tacrolimus/therapeutic use; Transplantation, Autologous; Vidarabine/administration & dosage

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Vidarabine / Salvage Therapy / Hematopoietic Stem Cell Transplantation / Transplantation Conditioning / Antilymphocyte Serum Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Bone Marrow Transplant Journal subject: TRANSPLANTE Year: 2007 Type: Article Affiliation country: United States

Search on Google

XML

PubMed Links